Advertisement Pharmaceutical Business review - Page 90 of 5297 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 4, 2026

FDA to review uniQure’s BLA for Huntington’s gene therapy

The US Food and Drug Administration (FDA) has accepted a biologics licence application (BLA) under its accelerated approval pathway from uniQure for ifezuntirgene inilparvovec, an investigational gene therapy to treat Huntington’s disease.

Continue
Huntington’s disease is an inherited disorder that causes motor symptoms, including chorea, behavioural changes, and progressive cognitive decline. Credit: H_Ko / Shutterstock.com.
November 4, 2026

GEBRO and Spektus sign collaboration for ActraFlex

ActraFlex combines paracetamol and tramadol into a formulation engineered to provide sustained release using a twice-daily dosing regimen. Credit: Tapati Rinchumrus / Shutterstock.com.
November 3, 2026

Lonza to acquire five US manufacturing sites from Merck KGaA

The acquisition follows other recent US investments by Lonza. Credit: Taljat David / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Bavarian Nordic secures four-year UK vaccine supply deal
  2. Inovio’s Voceryq receives FDA accelerated approval for RRP
  3. Pelthos and Castle Creek plan merger to target skin diseases
  4. Glenmark opens Allentown distribution hub in US
  5. Dren Bio raises $350m for dibotatug clinical development

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography